PTC Therapeutics Inc (PTCT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 CORPORATE COURT SOUTH PLAINFIELD, NJ 07080-2449

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules.

Data as of 2020-07-04
Market Cap3.477 Billion Shares Outstanding65.599 Million Avg 30-day Volume656.345 Thousand
P/E Ratio Dividend Yield EPS-4.88
Price/Sales14.697 Price cash flow ratio183.0 Price free cash flow ratio-22.1
Book Value8.06 Price to Tangible Book-13.07 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.059507
BETA1.39641 52-week High/Low59.89 / 30.7923 Stddev0.243772
View SEC Filings from PTCT instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 8 4 (0.26%)
13F Filers holding this stock: 199 68 (4.45%)
Aggregate 13F shares on 03/31/2020: 62.811 Million 35.351 Million
Aggregate 13F shares on 12/31/2019: 60.927 Million 29.698 Million
Percent change: 3.09% 19.03%
Funds creating new positions: 31 8
Funds Adding to an existing position: 80 27
Funds closing out their position: 33 13
Funds reducing their position: 68 28
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PTCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PTCT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

76.9 Thousand total shares from 25 transactions

Exercise Derivative Conversion (M)

74 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BOULDING MARK ELLIOTT EXEC. VP AND CLO

  • Officer
39,724 2020-07-07 2

UTTER CHRISTINE MARIE SVP, FINANCE & CAO

  • Officer
9,562 2020-07-06 6

KOPPEL ADAM

  • Director
  • 10% Owner
0 2020-06-30 0

SPIEGEL ROBERT J.

  • Director
106,298 2020-06-30 0

HILL EMILY LUISA CHIEF FINANCIAL OFFICER

  • Officer
13,610 2020-06-29 4

OKEY STEPHANIE

  • Director
0 2020-06-19 1

SVORONOS DAWN

  • Director
2,256 2020-06-17 2

SOUTHWELL DAVID P

0 2020-06-16 1

ALDRICH RICHARD

  • Director
0 2020-06-11 0

REEVE EMMA CHIEF FINANCIAL OFFICER

0 2020-06-08 1

SCHMERTZLER MICHAEL

  • 10% Owner
802,005 2020-06-05 2

ZELDIS JEROME B

  • Director
107,944 2020-05-28 1

PELTZ STUART WALTER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
56,085 2020-05-20 7

RENAUD RONALD C JR

  • Director
0 2020-04-29 0

JACOBSON ALLAN STEVEN

  • Director
8,498 2020-04-17 2

KLEIN MATTHEW B. CHIEF DEVELOPMENT OFFICER

  • Officer
10,000 2020-04-16 2

PAUWELS ERIC CHIEF BUSINESS OFFICER

  • Officer
33,841 2020-04-16 2

SOUZA MARCIO CHIEF OPERATING OFFICER

  • Officer
6,744 2020-02-10 5

ALMSTEAD NEIL GREGORY CHIEF TECHNICAL OPS OFFICER

  • Officer
29,001 2020-02-05 4

STEELE GLENN JR MD PHD

  • Director
1,650 2020-01-29 1

ROTHERA MARK SEE REMARKS

  • Officer
  • Director
103,796 2020-01-01 0

MCDONOUGH CAMERON GEOFFREY

  • Director
0 2019-06-26 0

ONG TUYEN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-06-07 0

KOVACS SHANE WILLIAM CHARLES CHIEF FINANCIAL OFFICER

  • Officer
37,850 2017-05-09 0

COMPLETE PHARMA HOLDINGS II, LLC

  • 10% Owner
No longer subject to file 2017-04-28 0

KRANDA MICHAEL L

  • Director
2,242 2015-03-16 0

HIRAWAT CLAUDIA DE OLIVEIRA RIBEIRO PRESIDENT

  • Officer
No longer subject to file 2015-01-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 600 $54.20 d 43,499 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 1,000 $54.20 d 51,849 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 M 17,500 $18.01 a 57,224 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 626 $54.18 d 44,225 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 100 $55.73 d 48,132 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 962 $55.31 d 51,413 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 100 $55.73 d 39,724 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 400 $55.74 d 44,099 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 3,775 $55.26 d 52,849 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 200 $55.73 d 39,724 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 2,881 $55.24 d 44,851 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 2,824 $55.22 d 48,232 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 474 $54.70 d 52,375 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 M 17,500 $18.01 d 26,250 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 3,675 $55.24 d 39,824 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 7,350 $55.23 d 44,499 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 600 $54.20 d 56,624 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 4,301 $55.23 d 39,924 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 400 $54.15 d 47,732 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 S 357 $54.11 d 51,056 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 M 13,125 $11.23 a 52,849 39,724.00 direct yes

BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

2020-07-07 M 13,125 $11.23 d 6,563 39,724.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 M 2,500 $18.01 d 17,855 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 S 2,000 $53.81 d 10,062 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 M 788 $11.23 a 10,350 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 M 788 $11.23 d 1,575 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 M 2,500 $18.01 a 12,062 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 S 500 $54.40 d 9,562 9,562.00 direct yes

UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

2020-07-06 S 788 $52.98 d 9,562 9,562.00 direct yes

HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

2020-06-29 S 2,581 $52.50 d 13,610 13,610.00 direct yes

SVORONOS DAWN - Director

2020-06-11 S 364 $48.36 d 26,286 26,286.00 direct

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 M 33,788 $10.85 d 203,030 56,085.00 direct yes

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 S 33,788 $50.00 d 56,085 56,085.00 direct yes

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 M 33,788 $10.85 a 89,873 56,085.00 direct yes

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-18 M 6,284 $10.85 a 62,369 56,085.00 direct yes

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-18 M 6,284 $10.85 d 236,818 56,085.00 direct yes

PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-18 S 6,284 $50.12 d 56,085 56,085.00 direct yes
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments